HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Polly Fish Selected Research

Thrombosis (Thrombus)

9/2009Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Polly Fish Research Topics

Disease

3Hemorrhage
09/2009 - 06/2006
3Myocardial Infarction
09/2009 - 06/2006
1Thrombosis (Thrombus)
09/2009
1Ischemic Stroke
09/2009
1Atherosclerosis
09/2009
1Peripheral Arterial Disease
09/2009
1ST Elevation Myocardial Infarction
10/2006
1Inflammation (Inflammations)
06/2006
1Ischemia
06/2006
1Acute Coronary Syndrome
06/2006

Drug/Important Bio-Agent (IBA)

2ThrombinFDA Link
09/2009 - 06/2006
2Eptifibatide (Integrilin)FDA Link
10/2006 - 06/2006
1vorapaxarIBA
09/2009
1PAR-1 ReceptorIBA
09/2009
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
09/2009
1bivalirudin (Angiomax)FDA Link
06/2006
1Fibrinolytic Agents (Antithrombotic Agents)IBA
06/2006
1Glycoproteins (Glycoprotein)IBA
06/2006
1Biomarkers (Surrogate Marker)IBA
06/2006
1AntithrombinsIBA
06/2006

Therapy/Procedure

2Percutaneous Coronary Intervention
10/2006 - 06/2006
1Therapeutics
10/2006